Found 10 matching trials
Dose Finding Study of Il-2 at Ultra-low Dose in Children With Recently Diagnosed Type 1 Diabetes PHASE2 Human recombinant interleukin-2 (rhIL-2) is a biological signalling protein...
Show More Location
Service d'Endocrinologie Pédiatrique
Learn More & Join Trial
Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak) PHASE2 This study examines the use of denileukin diftitox (Ontak) for patients wit...
Show More Location
Washington University
Learn More & Join Trial
Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata PHASE1 Alopecia areata is an autoimmune disease associated with infiltration of cl...
Show More Location
CHU de Nice - Hôpital Archet
Learn More & Join Trial
Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric Cancer PHASE1 The purpose of the trial is to assess the immunological effects and their k...
Show More Location
Institut für Klinische Forschung, Krankenhaus Nordwest GmbH
Learn More & Join Trial
Assessment of Efficacy and Safety of PD-1 Monoclonal Antibody Combined With IL-2 and CapeOX in Neoadjuvant Therapy for Locally Advanced Rectal Cancer Prior to Surgery: A Prospective, Multi-center, Randomized Controlled Study PHASE2 The objective is to evaluate whether the neoadjuvant combination of tisleli...
Show More Location
Nanjing BenQ Hospital
Learn More & Join Trial
MG4101 Plus Rituximab Including Lymphodepletion in Patient With r/r NHL B-cell Origin PHASE1 To determine the efficacy and safety of combined therapy of determined MG41...
Show More Location
Asan Medical Center
Learn More & Join Trial
PRaG Regimens Rechallenge for Patients With Resistance to PD1/PD-L1 Inhibitors in Refractory Advanced Solid Tumors. PHASE2 Finding an effective treatment to rescue with resistance of PD-1/PD-L1 inhi...
Show More Location
Multiple Locations
Learn More & Join Trial
Hypofractionated Radiotherapy Combined With PD-1 Inhibitor Sequential GM-CSF and IL-2 for the Treatment of Advanced Refractory Solid Tumors (PRaG2.0) PHASE2 This is a prospective multicenter clinical study to determine the efficacy ...
Show More Location
Peking University Third Hospital
Learn More & Join Trial
A Study to Evaluate Safety and Therapeutic Activity of RO6874281 in Combination with Pembrolizumab, in Participants with Advanced or Metastatic Melanoma PHASE1 This is an open-label, multicenter, Phase Ib study to evaluate the safety a...
Show More Learn More & Join Trial
Use of Low Doses of Interleukin-2 in Autism Spectrum Disorders PHASE2 Autism spectrum disorders (ASD) are neurodevelopmental disorders that affec...
Show More Location
Robert Debré Hospital
Learn More & Join Trial